These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6771963

  • 1. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
    Jagiełło-Wójtowicz.
    Acta Physiol Pol; 1980; 31(2):153-8. PubMed ID: 6771963
    [Abstract] [Full Text] [Related]

  • 2. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
    Kleinrok Z, Szponar J, Matuszek B, Jagiełło-Wójtowicz E.
    Pol J Pharmacol Pharm; 1990; 42(5):417-24. PubMed ID: 2098751
    [Abstract] [Full Text] [Related]

  • 3. The effect of baclofen and aminooxyacetic acid on the action of drugs stimulating the dopaminergic system.
    Sypniewska M.
    Pol J Pharmacol Pharm; 1978; 30(6):755-66. PubMed ID: 573471
    [Abstract] [Full Text] [Related]

  • 4. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E.
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [Abstract] [Full Text] [Related]

  • 5. Effect of gestational and neonatal styrene exposure on dopamine receptors.
    Zaidi NF, Agrawal AK, Srivastava SP, Seth PK.
    Neurobehav Toxicol Teratol; 1985; 7(1):23-8. PubMed ID: 4039799
    [Abstract] [Full Text] [Related]

  • 6. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
    Kleinrok Z, Ossowska G, Stelmasiak M, Juszkiewicz M.
    Pol J Pharmacol Pharm; 1983; 35(6):489-95. PubMed ID: 6377282
    [Abstract] [Full Text] [Related]

  • 7. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
    Wawrzyniuk I, Buczko W, Wiśniewski K.
    Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The involvement of serotonin in the mechanism of central action of apomorphine.
    Grabowska M.
    Pol J Pharmacol Pharm; 1976; 28(4):389-94. PubMed ID: 790347
    [Abstract] [Full Text] [Related]

  • 10. Central effects of octopamine administered into the lateral ventricle of rats.
    Kleinrok Z, Jagiełło-Wójtowicz E, Szkilnik E.
    Acta Physiol Pol; 1979; 30(4):445-53. PubMed ID: 228526
    [Abstract] [Full Text] [Related]

  • 11. Lithium inhibition of norepinephrine and dopamine receptors.
    Flemenbaum A.
    Biol Psychiatry; 1977 Aug; 12(4):563-72. PubMed ID: 560884
    [Abstract] [Full Text] [Related]

  • 12. The effect of bradykinin on central dopamine receptors.
    Przesmycki K, Kleinrok Z.
    Pol J Pharmacol Pharm; 1976 Aug; 28(6):673-8. PubMed ID: 1034925
    [Abstract] [Full Text] [Related]

  • 13. Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
    Getova D, Markovska V.
    Acta Physiol Pharmacol Bulg; 1988 Aug; 14(2):56-62. PubMed ID: 2851915
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Antidepressive effects of 3 endogenous monoamines: psychopharmacologic profiles of noradrenaline, octopamine and phenethylamine].
    Bulach C, Doaré L, Massari B, Simon P.
    J Pharmacol; 1984 Aug; 15(1):1-15. PubMed ID: 6425565
    [Abstract] [Full Text] [Related]

  • 20. Central action of adrenaline.
    Jagiełło-Wójtowicz E.
    Acta Physiol Pol; 1981 Aug; 32(2):169-80. PubMed ID: 7196677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.